In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | -100% |
2013 | $41.11 M | 277.58% |
2012 | $10.89 M | -5.17% |
2011 | $11.48 M | -31.68% |
2010 | $16.8 M | -18.26% |
2009 | $20.56 M | -67.73% |
2008 | $63.72 M | -3.43% |
2007 | $65.98 M | 22.38% |
2006 | $53.91 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |